Timber Pharmaceuticals LLC is a clinical-stage biopharmaceutical company that develops and sells treatments for rare dermatologic diseases. They have several products in different stages of clinical trials, including TMB-001 for subtypes of CI, TMB-002 for facial angiofibroma, and BPX-01 and BPX-04 for acne vulgaris and papulopustular rosacea. The company was founded in 2019 and is based in Basking Ridge, New Jersey.